The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia
- PMID: 14755719
- DOI: 10.1002/ana.10795
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia
Abstract
Familial parkinsonism and dementia with cortical and subcortical Lewy bodies is uncommon, and no genetic defect has been reported in the previously described sibships. We present a Spanish family with autosomal dominant parkinsonism, dementia, and visual hallucinations of variable severity. The postmortem examination showed atrophy of the substantia nigra, lack of Alzheimer pathology, and numerous Lewy bodies which were immunoreactive to alpha-synuclein and ubiquitin in cortical and subcortical areas. Sequencing of the alpha-synuclein gene showed a novel, nonconservative E46K mutation in heterozygosis. The E46K mutation was present in all affected family members and in three young asymptomatic subjects, but it was absent in healthy and pathological controls. The novel mutation, that substitutes a dicarboxylic amino acid, glutamic acid, with a basic amino acid such as lysine in a much conserved area of the protein, is likely to produce severe disturbance of protein function. Our data show that, in addition to the previously described hereditary alpha-synucleinopathies, dementia with Lewy bodies is related to mutation of alpha-synuclein.
Comment in
-
Alpha-synuclein in Parkinson's disease: light from two new angles.Ann Neurol. 2004 Feb;55(2):153-6. doi: 10.1002/ana.20036. Ann Neurol. 2004. PMID: 14755715 No abstract available.
Similar articles
-
Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.Exp Neurol. 1998 Dec;154(2):684-90. doi: 10.1006/exnr.1998.6975. Exp Neurol. 1998. PMID: 9878203
-
Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.FEBS Lett. 2004 Oct 22;576(3):363-8. doi: 10.1016/j.febslet.2004.09.038. FEBS Lett. 2004. PMID: 15498564
-
[Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].Rinsho Shinkeigaku. 1999 Dec;39(12):1285-6. Rinsho Shinkeigaku. 1999. PMID: 10791099 Japanese.
-
Neuropathological spectrum of synucleinopathies.Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
-
Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.Neuron. 2006 Oct 5;52(1):33-8. doi: 10.1016/j.neuron.2006.09.026. Neuron. 2006. PMID: 17015225 Review.
Cited by
-
Biomarkers and the Role of α-Synuclein in Parkinson's Disease.Front Aging Neurosci. 2021 Mar 23;13:645996. doi: 10.3389/fnagi.2021.645996. eCollection 2021. Front Aging Neurosci. 2021. PMID: 33833675 Free PMC article.
-
Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation.Front Mol Neurosci. 2021 Apr 12;14:659926. doi: 10.3389/fnmol.2021.659926. eCollection 2021. Front Mol Neurosci. 2021. PMID: 33912013 Free PMC article.
-
A-Syn(ful) MAM: A Fresh Perspective on a Converging Domain in Parkinson's Disease.Int J Mol Sci. 2024 Jun 13;25(12):6525. doi: 10.3390/ijms25126525. Int J Mol Sci. 2024. PMID: 38928232 Free PMC article. Review.
-
Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.J Biol Chem. 2013 May 24;288(21):15194-210. doi: 10.1074/jbc.M113.457408. Epub 2013 Mar 26. J Biol Chem. 2013. PMID: 23532841 Free PMC article.
-
Alpha-synuclein function and dysfunction on cellular membranes.Exp Neurobiol. 2014 Dec;23(4):292-313. doi: 10.5607/en.2014.23.4.292. Epub 2014 Dec 12. Exp Neurobiol. 2014. PMID: 25548530 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous